THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 133 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $403,479 | -5.4% | 47,580 | +0.0% | 0.01% | 0.0% |
| Q1 2024 | $426,650 | -22.0% | 47,564 | -2.3% | 0.01% | -18.2% |
| Q4 2023 | $546,985 | -19.4% | 48,664 | -38.2% | 0.01% | -21.4% |
| Q3 2023 | $679,044 | -16.6% | 78,684 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $814,380 | -2.2% | 78,684 | +2.5% | 0.02% | 0.0% |
| Q1 2023 | $833,097 | +22.2% | 76,783 | +26.4% | 0.02% | +23.1% |
| Q4 2022 | $681,526 | +310.6% | 60,742 | +442.3% | 0.01% | +550.0% |
| Q3 2020 | $166,000 | -19.4% | 11,200 | +14.3% | 0.00% | 0.0% |
| Q2 2020 | $206,000 | – | 9,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
| Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
| Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
| Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
| Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
| Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
| Baupost Group | 4,200,021 | $35,616 | 0.98% |
| Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
| Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |